These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 11007942)

  • 1. Inhibitors of prenylation of Ras and other G-proteins and their application as therapeutics.
    Cohen LH; Pieterman E; van Leeuwen RE; Overhand M; Burm BE; van der Marel GA; van Boom JH
    Biochem Pharmacol; 2000 Oct; 60(8):1061-8. PubMed ID: 11007942
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of human smooth muscle cell proliferation in culture by farnesyl pyrophosphate analogues, inhibitors of in vitro protein: farnesyl transferase.
    Cohen LH; Pieterman E; van Leeuwen RE; Du J; Negre-Aminou P; Valentijn AR; Overhand M; van der Marel GA; van Boom JH
    Biochem Pharmacol; 1999 Feb; 57(4):365-73. PubMed ID: 9933024
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential prenyl pyrophosphate binding to mammalian protein geranylgeranyltransferase-I and protein farnesyltransferase and its consequence on the specificity of protein prenylation.
    Yokoyama K; Zimmerman K; Scholten J; Gelb MH
    J Biol Chem; 1997 Feb; 272(7):3944-52. PubMed ID: 9020098
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of farnesyl:protein transferase and geranylgeranyl:protein transferase inhibitor combinations in preclinical models.
    Lobell RB; Omer CA; Abrams MT; Bhimnathwala HG; Brucker MJ; Buser CA; Davide JP; deSolms SJ; Dinsmore CJ; Ellis-Hutchings MS; Kral AM; Liu D; Lumma WC; Machotka SV; Rands E; Williams TM; Graham SL; Hartman GD; Oliff AI; Heimbrook DC; Kohl NE
    Cancer Res; 2001 Dec; 61(24):8758-68. PubMed ID: 11751396
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protein farnesyltransferase: measurement of enzymatic activity in 96-well format using TopCount microplate scintillation counting technology.
    Harwood HJ
    Anal Biochem; 1995 Apr; 226(2):268-78. PubMed ID: 7793628
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 2-Arylindole-3-acetamides: FPP-competitive inhibitors of farnesyl protein transferase.
    Trotter BW; Quigley AG; Lumma WC; Sisko JT; Walsh ES; Hamann CS; Robinson RG; Bhimnathwala H; Kolodin DG; Zheng W; Buser CA; Huber HE; Lobell RB; Kohl NE; Williams TM; Graham SL; Dinsmore CJ
    Bioorg Med Chem Lett; 2001 Apr; 11(7):865-9. PubMed ID: 11294379
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of SCH 59228, an orally bioavailable farnesyl protein transferase inhibitor, on the growth of oncogene-transformed fibroblasts and a human colon carcinoma xenograft in nude mice.
    Liu M; Bryant MS; Chen J; Lee S; Yaremko B; Li Z; Dell J; Lipari P; Malkowski M; Prioli N; Rossman RR; Korfmacher WA; Nomeir AA; Lin CC; Mallams AK; Doll RJ; Catino JJ; Girijavallabhan VM; Kirschmeier P; Bishop WR
    Cancer Chemother Pharmacol; 1999; 43(1):50-8. PubMed ID: 9923541
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clavaric acid and steroidal analogues as Ras- and FPP-directed inhibitors of human farnesyl-protein transferase.
    Lingham RB; Silverman KC; Jayasuriya H; Kim BM; Amo SE; Wilson FR; Rew DJ; Schaber MD; Bergstrom JD; Koblan KS; Graham SL; Kohl NE; Gibbs JB; Singh SB
    J Med Chem; 1998 Nov; 41(23):4492-501. PubMed ID: 9804689
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of the prenylation of K-Ras, but not H- or N-Ras, is highly resistant to CAAX peptidomimetics and requires both a farnesyltransferase and a geranylgeranyltransferase I inhibitor in human tumor cell lines.
    Lerner EC; Zhang TT; Knowles DB; Qian Y; Hamilton AD; Sebti SM
    Oncogene; 1997 Sep; 15(11):1283-8. PubMed ID: 9315095
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protein prenylation contributes to the effects of LPS on EFS-induced responses in human isolated bronchi.
    Cazzola M; Calzetta L; Page CP; Rinaldi B; Capuano A; Matera MG
    Am J Respir Cell Mol Biol; 2011 Oct; 45(4):704-10. PubMed ID: 21278325
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MEK and ERK activation in ras-disabled RBL-2H3 mast cells and novel roles for geranylgeranylated and farnesylated proteins in Fc epsilonRI-mediated signaling.
    Graham TE; Pfeiffer JR; Lee RJ; Kusewitt DF; Martinez AM; Foutz T; Wilson BS; Oliver JM
    J Immunol; 1998 Dec; 161(12):6733-44. PubMed ID: 9862703
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Manumycin and gliotoxin derivative KT7595 block Ras farnesylation and cell growth but do not disturb lamin farnesylation and localization in human tumour cells.
    Nagase T; Kawata S; Tamura S; Matsuda Y; Inui Y; Yamasaki E; Ishiguro H; Ito T; Miyagawa J; Mitsui H; Yamamoto K; Kinoshita M; Matsuzawa Y
    Br J Cancer; 1997; 76(8):1001-10. PubMed ID: 9376258
    [TBL] [Abstract][Full Text] [Related]  

  • 13. From pure FPP to mixed FPP and CAAX competitive inhibitors of farnesyl protein transferase.
    Lannuzel M; Lamothe M; Schambel P; Etiévant C; Hill B; Perez M
    Bioorg Med Chem Lett; 2003 Apr; 13(8):1459-62. PubMed ID: 12668012
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibiting geranylgeranylation blocks growth and promotes apoptosis in pulmonary vascular smooth muscle cells.
    Stark WW; Blaskovich MA; Johnson BA; Qian Y; Vasudevan A; Pitt B; Hamilton AD; Sebti SM; Davies P
    Am J Physiol; 1998 Jul; 275(1):L55-63. PubMed ID: 9688935
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of Ha-ras, N-ras, Ki-Ras4A, and Ki-Ras4B as in vitro substrates for farnesyl protein transferase and geranylgeranyl protein transferase type I.
    Zhang FL; Kirschmeier P; Carr D; James L; Bond RW; Wang L; Patton R; Windsor WT; Syto R; Zhang R; Bishop WR
    J Biol Chem; 1997 Apr; 272(15):10232-9. PubMed ID: 9092572
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combination of the novel farnesyltransferase inhibitor RPR130401 and the geranylgeranyltransferase-1 inhibitor GGTI-298 disrupts MAP kinase activation and G(1)-S transition in Ki-Ras-overexpressing transformed adrenocortical cells.
    Mazet JL; Padieu M; Osman H; Maume G; Mailliet P; Dereu N; Hamilton AD; Lavelle F; Sebti SM; Maume BF
    FEBS Lett; 1999 Oct; 460(2):235-40. PubMed ID: 10544242
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bisubstrate inhibitors of farnesyltransferase: a novel class of specific inhibitors of ras transformed cells.
    Manne V; Yan N; Carboni JM; Tuomari AV; Ricca CS; Brown JG; Andahazy ML; Schmidt RJ; Patel D; Zahler R
    Oncogene; 1995 May; 10(9):1763-79. PubMed ID: 7753553
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and evaluation of a novel series of farnesyl protein transferase inhibitors as non-peptidic CAAX tetrapeptide analogues.
    Perez M; Maraval C; Dumond S; Lamothe M; Schambel P; Etiévant C; Hill B
    Bioorg Med Chem Lett; 2003 Apr; 13(8):1455-8. PubMed ID: 12668011
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular targets of the nitrogen containing bisphosphonates: the molecular pharmacology of prenyl synthase inhibition.
    Dunford JE
    Curr Pharm Des; 2010; 16(27):2961-9. PubMed ID: 20722615
    [TBL] [Abstract][Full Text] [Related]  

  • 20. K- and N-Ras are geranylgeranylated in cells treated with farnesyl protein transferase inhibitors.
    Whyte DB; Kirschmeier P; Hockenberry TN; Nunez-Oliva I; James L; Catino JJ; Bishop WR; Pai JK
    J Biol Chem; 1997 May; 272(22):14459-64. PubMed ID: 9162087
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.